As CRC cells progressed, as indicated by KRAS expression, the expression of tumor acidosis markers (LAMP2, GLUT1, and LDHA), as well as dysadherin, also increased (Fig. 1b, Supplementary Fig. 1c). The gene discussed is LAMP2; the disease is neoplasm.